Market Size
The global high performance medical plastics market size was valued at USD 851 million in 2020 and is estimated to reach a value of USD xx billion in 2027. The high performance medical plastics market analysis shows that it will grow with a CAGR of 7.8% over the forecast period of 2021 to 2027.
Market Driver
The ageing population's demand for advanced medical instruments, as well as rising healthcare investments in developing economies like China and India, are the primary drivers of the high-performance medical plastics industry. Minimally invasive surgeries and operations are those that need less incisions and have a shorter healing period. Traditional open surgeries involved a long period of healing and recovery. As a result, minimally invasive treatments are gaining popularity. The rising prevalence of diseases that require complicated surgical therapies, such as arthritis, cancer, and cardiovascular disease, has raised demand for minimally invasive procedures.
High-performance medical plastics reduce manufacturing costs by improving workability and reducing time spent on instruments, supplies, and other materials. For example, cardiac and urinary catheterization, which involves the use of short catheter tubing, decreases the time required for the medical or surgical operation in question, and the use of plastics in their manufacture renders them compact, cost-effective, and simple to use. As a result, the rising need for minimally invasive surgical procedures, as well as the need to improve the quality of such procedures, are pushing demand for high-performance medical plastics.
In recent years, patient-specific technology has grown in importance. Patient-Specific Instrumentation (PSI) was developed to get personalized instruments like implants, which allowed users more accuracy and reduced recovery time and costs. In PSI, data is collected from surgeons, CT, or MRI scans, and then custom-made disposable cutting blocks are created using specialized software programs. Preoperatively, the surgeon may change the orientation and depth. As a result of the customization, the blocks are supposed to match more precisely and achieve greater alignment than traditional jigs. After that, the jigs are used to make personalized implants.
Segment Outlook
Based on resin type, the market is segmented into FP, HPPA, PAEK, PPS, PEI and Others. The Fluoropolymer (FP) segment is estimated to be the largest segment over the forecast period. Based on application, the market is segmented into Medical Supplies, Medical Equipment & Tools, Drug Delivery, Prosthesis & Implants, Therapeutic System and Others. The Medical Equipment & Tools application segment is estimated to be the largest segment over the forecast period.
Regional Outlook
The High Performance Medical Plastics market research report provides an in-depth analysis of the industry, incorporating quantitative and qualitative data. It includes historical, present, and forecast data of the global market for high performance medical plastics by segment. Furthermore, it provides market size and forecast estimates for five regions, namely Asia Pacific, North America, Europe, Central & South America, Middle East, and Africa from 2015 to 2027. The market for High Performance Medical Plastics is segmented by region and then by country and segment. It has been estimated that North America accounted for largest market share in global high performance medical plastics market. The key countries in this market include U.S., Italy, Germany, France, China, India, and Japan.
The report analyzes supply and demand-side factors affecting High Performance Medical Plastics market and then evaluates market dynamics affecting the market in coming years. Qualitative insight available in this report are opportunities, drivers, restraints, and future trends.
Company Profile Outlook
Key companies profiled in this market are Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US). However, we have also considered other companies for detailed primary interviews.
Research Methodology
High Performance Medical Plastics market report consists of market analysis including both primary and secondary research. Primary research comprises of the interaction between manufacturers, industry experts, channel partners, and end users, while the secondary research presents an analytical interpretation of relevant published databases, which contains details like company annual reports, and financial reports, white papers, and purchased databases.
For single, team and corporate user license, we will provide 15% free customization of the report. However, alternatively, if you are looking for additional data or insight related to the scope of the report, you may purchase the "Customized Research License". Please put an enquiry for the pricing details.
About Us
Market Insight Solutions is a leading market research firm which caters to a diverse portfolio of research campaigns. We are one of the fastest growing research organization led by an extensive team of individuals. Our team has individuals with more than 10 years of experience in diverse research domains. Our strategic insights aim at providing credible and practical solutions to meet the specific requirements of our clients. We offer market studies on basis of facts across cross domains.
Segments covered in the report
High Performance Medical Plastics Market Size and Outlook by Type
- Fluoropolymers (FP)
- High Performance Polyamides (HPPA)
- Polyaryletherketones (PAEK)
- Polyphenylene Sulfides (PPS)
- Polyetherimide (PEI)
- Others
High Performance Medical Plastics Market Size and Outlook by Application
- Medical Equipment & Tools
- Medical Supplies
- Drug Delivery
- Prosthesis & Implants
- Therapeutic System
- Others
High Performance Medical Plastics Market Size and Outlook by Region
- North America
- Europe
- UK
- France
- Germany
- Russia
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Indonesia
- South Korea
- Australia
- Central & South America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Companies Profiled in this Report
- Solvay SA
- SABIC
- Mitsubishi Chemical Corporation
- Evonik Industries AG
- Arkema SA
- Ensinger
- Victrex PLC
- Rochling SE & Co. AG
- Raumedic AG
- The Chemours Company
- DuPont
- Saint-Gobain Performance Plastics
- Celanese Corporation
- Trelleborg
- Tekni-Plex (US)
Actionable Outcomes
Our High Performance Medical Plastics Market Report offers a thorough assessment of estimations and projections on the market dynamics. Further, it helps in the implementation of these results as they show tangible benefits to business stakeholders and industry entities decisions as leaders.
Strategic Planning
Every business needs to understand how their product will grow in the forthcoming years. With the current uncertainness due to the COVID-19 scenario, this analysis becomes significant to understand past disruptions and boost the preparedness for the next steps of decision. We at Market Insight Solutions are trying to break down the complex market for the business leaders through strategic insights and resilience in unpredictable situations.
Highlights of the report:
- COVID-19 impact on High Performance Medical Plastics market size
- High Performance Medical Plastics market size, drifts, drivers and opportunities
- Analyzing the regional market for the growth factors, estimated analysis and its penetration to the global market
- High Performance Medical Plastics market size in United States
- Understanding the dynamics of the parent market
- Prime fluctuations of the market dynamics
- Evaluation of the market opportunities
- Historical, current, and projected High Performance Medical Plastics market size from the standpoint of both value and volume
- Market segmentation and comprehensive analysis in the second or third level
- Reporting and evaluation of recent industry developments
- Analysis of market share and developments
- Detailed company profiling of leading companies
- Opportunities to newer markets in global and regional markets
- Analyzing the trajectory line of the business
- Analyze High Performance Medical Plastics market share
- Measures to consider for High Performance Medical Plastics market
